4//SEC Filing
Kirschbaum Mark 4
Accession 0001104659-21-150000
CIK 0001130166other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:18 PM ET
Size
5.6 KB
Accession
0001104659-21-150000
Insider Transaction Report
Form 4
Kirschbaum Mark
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-12-13+100,000→ 100,000 totalExercise: $3.45Exp: 2031-12-13→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis.
- [F2]These securities were granted as part of the Issuer's annual compensation review to executive officers.
Documents
Issuer
Cyclacel Pharmaceuticals, Inc.
CIK 0001130166
Entity typeother
Related Parties
1- filerCIK 0001830211
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 4:18 PM ET
- Size
- 5.6 KB